4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 101 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 39,083 | $706,230 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 18,920 | $342 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 13,616 | $246 | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 1,882 | $34,008 | 0.00% |
| Russell Investments Group, Ltd. | 1,126 | $20,346 | 0.00% |
External links
This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q2 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.